Despite Prime Minister Boris Johnson's claim that 70% of personal protective equipment (PPE) is to be made in the UK, his government's own figures suggest the total is likely to be closer to a third.

More than 3.5 billion items, including aprons, goggles, facemasks and gloves, have been bought by the government this year to protect NHS and social care staff from the spread of coronavirus.

As the virus took hold in the spring, the battle to get hold of protective gear in the face of soaring global demand and disruption to supply chains was likened by experts to the Wild West.

In July, it was revealed that £15bn had been allocated by the Treasury to buy such kit - equivalent to about £200 per person.

With more than 80% of PPE items initially produced in China, concerns were growing not just about cost but the ability of the UK to be self-sufficient in key equipment.

The prime minister sought to reassure over the UK's preparedness for a second wave when he addressed the nation on Wednesday. He said that by December "we expect 70% of the demand for PPE to be met by UK manufacturers, compared to just 1% before the pandemic".

Contract concerns
But the government's own PPE strategy, published just the day before, makes clear that this 70% number excludes gloves - which, according to its figures, make up over half of all PPE being distributed.

The raw materials used in gloves means that no British supplier has been found. Include gloves, and the total number of items that will be UK-sourced appears to be more like a third.

Despite Prime Minister Boris Johnson's claim that 70% of personal protective equipment (PPE) is to be made in the UK, his government's own figures suggest the total is likely to be closer to a third.

More than 3.5 billion items, including aprons, goggles, facemasks and gloves, have been bought by the government this year to protect NHS and social care staff from the spread of coronavirus.

As the virus took hold in the spring, the battle to get hold of protective gear in the face of soaring global demand and disruption to supply chains was likened by experts to the Wild West.

In July, it was revealed that £15bn had been allocated by the Treasury to buy such kit - equivalent to about £200 per person.

With more than 80% of PPE items initially produced in China, concerns were growing not just about cost but the ability of the UK to be self-sufficient in key equipment.

The prime minister sought to reassure over the UK's preparedness for a second wave when he addressed the nation on Wednesday. He said that by December "we expect 70% of the demand for PPE to be met by UK manufacturers, compared to just 1% before the pandemic".

Contract concerns
But the government's own PPE strategy, published just the day before, makes clear that this 70% number excludes gloves - which, according to its figures, make up over half of all PPE being distributed.

The raw materials used in gloves means that no British supplier has been found. Include gloves, and the total number of items that will be UK-sourced appears to be more like a third.

(CNN) President Donald Trump will be administered 2 doses of Sinovac vaccine. Thereafter, no one can say anything about him not wearing masks anymore.

(CNN) President Donald Trump has ordered the lifting of the CBP ban on Top Glove Sdn Bhd with immediate effect due to glove shortage at the White House.

The present share prices of Carepls, Supermx and Topglov are at cheap sale price. Please check the target price set up by Citibank, Credit Suisse, Affin Hwang and CIMB. Any upside > 30% is considered as a good buy. No stock in KLSE can generate this type of EPS or PAT. Procrastination will hinder your chance to win big.

No stock in KLSE can generate a PAT of > 10 billion in FY 2021 except Topglov. Maybank is still very far away to go near Topglov. EPF should buy Topglov at current cheap price. The target price set by Credit Suisse is 16.20.
EPF is buying Topglov today !! EPF is flooded with cash, no more waiting like many investors here.

Mr OTB, any reason why Careplus instead of Comfort for second liner ? ------
Ans : TA chart of Carepls is better than Comfort. I have to tell the truth even though I have very good luck on Comfort. I never lose a single trade on Comfort in 2020.

I believe it is the best opportunity to win big in KLSE. The second wave of Covid-19 pandemic will push the share prices of Carepls, Supermx and Topglov to new highs. My good friend Purebull sifu said the current uptrend is Primary Third Wave up after Primary Second Wave down correction. I believe the correction is over, we will see blue sky very soon. Mercator WA and Intco Medical are also displayed the same trend, Primary Third Wave Up.

The final decision to buy is always yours.
Thank you.

The present share prices of Carepls, Supermx and Topglov are at cheap sale price. Please check the target price set up by Citibank, Credit Suisse, Affin Hwang and CIMB. Any upside > 30% is considered as a good buy. No stock in KLSE can generate this type of EPS or PAT. Procrastination will hinder your chance to win big.

No stock in KLSE can generate a PAT of > 10 billion in FY 2021 except Topglov. Maybank is still very far away to go near Topglov. EPF should buy Topglov at current cheap price. The target price set by Credit Suisse is 16.20.
EPF is buying Topglov today !! EPF is flooded with cash, no more waiting like many investors here.

Mr OTB, any reason why Careplus instead of Comfort for second liner ? ------
Ans : TA chart of Carepls is better than Comfort. I have to tell the truth even though I have very good luck on Comfort. I never lose a single trade on Comfort in 2020.

I believe it is the best opportunity to win big in KLSE. The second wave of Covid-19 pandemic will push the share prices of Carepls, Supermx and Topglov to new highs. My good friend Purebull sifu said the current uptrend is Primary Third Wave up after Primary Second Wave down correction. I believe the correction is over, we will see blue sky very soon. Mercator WA and Intco Medical are also displayed the same trend, Primary Third Wave Up.

The final decision to buy is always yours.
Thank you.

The present share prices of Carepls, Supermx and Topglov are at cheap sale price. Please check the target price set up by Citibank, Credit Suisse, Affin Hwang and CIMB. Any upside > 30% is considered as a good buy. No stock in KLSE can generate this type of EPS or PAT. Procrastination will hinder your chance to win big.

No stock in KLSE can generate a PAT of > 10 billion in FY 2021 except Topglov. Maybank is still very far away to go near Topglov. EPF should buy Topglov at current cheap price. The target price set by Credit Suisse is 16.20.
EPF is buying Topglov today !! EPF is flooded with cash, no more waiting like many investors here.

Mr OTB, any reason why Careplus instead of Comfort for second liner ? ------
Ans : TA chart of Carepls is better than Comfort. I have to tell the truth even though I have very good luck on Comfort. I never lose a single trade on Comfort in 2020.

I believe it is the best opportunity to win big in KLSE. The second wave of Covid-19 pandemic will push the share prices of Carepls, Supermx and Topglov to new highs. My good friend Purebull sifu said the current uptrend is Primary Third Wave up after Primary Second Wave down correction. I believe the correction is over, we will see blue sky very soon. Mercator WA and Intco Medical are also displayed the same trend, Primary Third Wave Up.

The final decision to buy is always yours.
Thank you.

confirm warisan win

The present share prices of Carepls, Supermx and Topglov are at cheap sale price. Please check the target price set up by Citibank, Credit Suisse, Affin Hwang and CIMB. Any upside > 30% is considered as a good buy. No stock in KLSE can generate this type of EPS or PAT. Procrastination will hinder your chance to win big.

No stock in KLSE can generate a PAT of > 10 billion in FY 2021 except Topglov. Maybank is still very far away to go near Topglov. EPF should buy Topglov at current cheap price. The target price set by Credit Suisse is 16.20.
EPF is buying Topglov today !! EPF is flooded with cash, no more waiting like many investors here.

Mr OTB, any reason why Careplus instead of Comfort for second liner ? ------
Ans : TA chart of Carepls is better than Comfort. I have to tell the truth even though I have very good luck on Comfort. I never lose a single trade on Comfort in 2020.

I believe it is the best opportunity to win big in KLSE. The second wave of Covid-19 pandemic will push the share prices of Carepls, Supermx and Topglov to new highs. My good friend Purebull sifu said the current uptrend is Primary Third Wave up after Primary Second Wave down correction. I believe the correction is over, we will see blue sky very soon. Mercator WA and Intco Medical are also displayed the same trend, Primary Third Wave Up.

The final decision to buy is always yours.
Thank you.

The second wave of Covid-19 started now.
The share price of Mercator WA hits all time high.
Carepls, Supermx and Topglov will perform well.
Tq. Ooi

The present share prices of Carepls, Supermx and Topglov are at cheap sale price. Please check the target price set up by Citibank, Credit Suisse, Affin Hwang and CIMB. Any upside > 30% is considered as a good buy. No stock in KLSE can generate this type of EPS or PAT. Procrastination will hinder your chance to win big.

No stock in KLSE can generate a PAT of > 10 billion in FY 2021 except Topglov. Maybank is still very far away to go near Topglov. EPF should buy Topglov at current cheap price. The target price set by Credit Suisse is 16.20.
EPF is buying Topglov today !! EPF is flooded with cash, no more waiting like many investors here.

Mr OTB, any reason why Careplus instead of Comfort for second liner ? ------
Ans : TA chart of Carepls is better than Comfort. I have to tell the truth even though I have very good luck on Comfort. I never lose a single trade on Comfort in 2020.

I believe it is the best opportunity to win big in KLSE. The second wave of Covid-19 pandemic will push the share prices of Carepls, Supermx and Topglov to new highs. My good friend Purebull sifu said the current uptrend is Primary Third Wave up after Primary Second Wave down correction. I believe the correction is over, we will see blue sky very soon. Mercator WA and Intco Medical are also displayed the same trend, Primary Third Wave Up.

The final decision to buy is always yours.
Thank you.